Douglass Winthrop Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $386K | Hold |
|
|||||
|
2025
Q1 | $421K | Sell |
|
|||||
|
2024
Q4 | $370K | Hold |
|
|||||
|
2024
Q3 | $427K | Sell |
|
|||||
|
2024
Q2 | $442K | Buy |
|
|||||
|
2024
Q1 | $392K | Hold |
|
|||||
|
2023
Q4 | $381K | Hold |
|
|||||
|
2023
Q3 | $326K | Buy |
|
|||||
|
2023
Q2 | $323K | Hold |
|
|||||
|
2023
Q1 | $289K | Hold |
|
|||||
|
2022
Q4 | $265K | Hold |
|
|||||
|
2022
Q3 | $266K | Hold |
|
|||||
|
2022
Q2 | $259K | Hold |
|
|||||
|
2022
Q1 | $240K | Hold |
|
|||||
|
2021
Q4 | $202K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $225K | Sell |
|
|||||
|
2020
Q3 | $318K | Sell |
|
|||||
|
2020
Q2 | $397K | Sell |
|
|||||
|
2020
Q1 | $343K | Sell |
|
|||||
|
2019
Q4 | $338K | Hold |
|
|||||
|
2019
Q3 | $262K | Hold |
|
|||||
|
2019
Q2 | $283K | Hold |
|
|||||
|
2019
Q1 | $284K | Hold |
|
|||||
|
2018
Q4 | $256K | Sell |
|
|||||
|
2018
Q3 | $318K | Sell |
|
|||||
|
2018
Q2 | $314K | Sell |
|
|||||
|
2018
Q1 | $345K | Sell |
|
|||||
|
2017
Q4 | $318K | Hold |
|
|||||
|
2017
Q3 | $323K | Buy |
|
|||||
|
2017
Q2 | $271K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $262K | Buy |
|
|||||
|
2016
Q2 | $215K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $315K | Hold |
|
|||||
|
2015
Q3 | $260K | Hold |
|
|||||
|
2015
Q2 | $295K | Hold |
|
|||||
|
2015
Q1 | $295K | Buy |
|